30 gen 2018 anni - FDA held a public hearing, “Opioid Policy
Steering Committee: Prescribing Intervention-
Exploring a Strategy for Implementation”
FDA announced limits to packaging for anti-
diarrhea medicine Loperamide (Imodium) to
encourage safe use.
FDA posted the revised Blueprint, “Opioid
Analgesic REMS Education Blueprint for Health
Care Providers Involved in the Treatment and
Monitoring of Patients with Pain,” which
broadens the current Blueprint to include
information on pain management, including the
principles o